X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aspirin (63) 63
index medicus (57) 57
humans (43) 43
cardiac & cardiovascular systems (35) 35
clopidogrel (35) 35
cardiology (30) 30
coronary heart disease (29) 29
acute coronary syndrome (25) 25
acute coronary syndromes (24) 24
cardiac patients (24) 24
care and treatment (23) 23
dual antiplatelet therapy (23) 23
platelet aggregation inhibitors - administration & dosage (22) 22
platelet aggregation inhibitors - adverse effects (22) 22
thrombosis (22) 22
stents (20) 20
cardiovascular disease (19) 19
stroke (19) 19
coronary artery disease (18) 18
heart attacks (18) 18
medicine & public health (18) 18
myocardial-infarction (18) 18
association task-force (17) 17
hemorrhage - chemically induced (17) 17
intervention (17) 17
patients (17) 17
percutaneous coronary intervention (17) 17
aspirin - administration & dosage (16) 16
bleeding (16) 16
pharmacology & pharmacy (16) 16
platelet aggregation inhibitors - therapeutic use (16) 16
ticagrelor (16) 16
treatment outcome (16) 16
abridged index medicus (15) 15
anticoagulants (15) 15
antiplatelet therapy (15) 15
focused update (15) 15
therapy (15) 15
drug therapy, combination (14) 14
percutaneous coronary intervention - adverse effects (14) 14
ticlopidine - analogs & derivatives (14) 14
time factors (14) 14
cardiovascular diseases (13) 13
mortality (13) 13
blood platelets (12) 12
clinical trials (12) 12
coronary vessels (12) 12
peripheral vascular disease (12) 12
transluminal angioplasty (12) 12
acute coronary syndrome - drug therapy (11) 11
acute myocardial-infarction (11) 11
american-college (11) 11
artery-disease (11) 11
platelet inhibition (11) 11
risk factors (11) 11
stent (11) 11
ticlopidine - administration & dosage (11) 11
analysis (10) 10
elevation myocardial-infarction (10) 10
male (10) 10
myocardial infarction (10) 10
prasugrel (10) 10
aspirin - adverse effects (9) 9
cardiac arrhythmia (9) 9
clinical-outcomes (9) 9
coronary stents (9) 9
drug-eluting stents (9) 9
eluting stent implantation (9) 9
female (9) 9
middle aged (9) 9
percutaneous coronary intervention - instrumentation (9) 9
prevention (9) 9
review (9) 9
stable ischemic heart disease (9) 9
usage (9) 9
aged (8) 8
angioplasty (8) 8
antithrombotic therapy (8) 8
atrial fibrillation (8) 8
drug administration schedule (8) 8
drug-eluting stent (8) 8
heart (8) 8
purinergic p2y receptor antagonists - administration & dosage (8) 8
risk (8) 8
secondary prevention (8) 8
studies (8) 8
surgery (8) 8
disease prevention (7) 7
dosage and administration (7) 7
drug dosages (7) 7
drug therapy (7) 7
implantation (7) 7
implants (7) 7
internal medicine (7) 7
low-dose aspirin (7) 7
pharmacology/toxicology (7) 7
proton pump inhibitors (7) 7
thromboembolism (7) 7
acute coronary syndrome - diagnosis (6) 6
adenosine - analogs & derivatives (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 10, pp. 1082 - 1115
Journal Article
Circulation, ISSN 0009-7322, 09/2016, Volume 134, Issue 10, pp. e123 - e155
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2016, Volume 68, Issue 10, pp. 1116 - 1139
Journal Article
Journal of Thoracic and Cardiovascular Surgery, The, ISSN 0022-5223, 2016, Volume 152, Issue 5, pp. 1243 - 1275
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 03/2018, Volume 197, pp. 77 - 84
Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor reduces thrombotic events in patients undergoing percutaneous coronary intervention (PCI),... 
DEFINITIONS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | CLOPIDOGREL | MYOCARDIAL-INFARCTION | DOUBLE-BLIND | ASPIRIN | INTERVENTION | DURATION | FOCUSED UPDATE | GUIDELINE | Purinergic P2Y Receptor Antagonists - administration & dosage | Outcome Assessment (Health Care) | Humans | Coronary Restenosis - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Drug Therapy, Combination - methods | Percutaneous Coronary Intervention - instrumentation | Purinergic P2Y Receptor Antagonists - classification | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Platelet Aggregation Inhibitors - administration & dosage | Adult | Female | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Myocardial Ischemia - surgery | Republic of Korea | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Intervention | Myocardial infarction | Therapy | Surgical implants | Thoracic surgery | Heart attacks | Sirolimus | Transplants & implants | Cardiovascular disease | Drug delivery | Drug development | Cobalt | Bleeding | Consortia | Cerebrovascular system | Biomedical materials | Randomization | Ischemia | Blood platelets | Platinum | Implants | Biocompatibility | Thromboembolism | Cardiology | Stents | Heart diseases | Anticoagulants | Task forces | Stroke | Aspirin | Mortality | Implantation | Chromium plating | Patients | Thrombosis | Coronary artery disease | Studies | Hypotheses | Composite materials | Inhibitors | Coronary vessels | Chromium | Clopidogrel | Infarction | Cobalt plating
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1025 - 1034
Journal Article